Dr. Deebeanne M. Tavani, DO PHD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
100 E Lancaster Ave, Lankenau Medical Bldg East Suite 463
Wynnewood, PA 19096
- Medicare participating
At a glance
- Medical school
- Philadelphia College of Osteopathic Medicine (1986)
- Years since graduation
- 40
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 691
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1986Medical school: Philadelphia College of Osteopathic Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
PA license OS006178L
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hospital of Univ of Pennsylvania Philadelphia, PA
- Main Line Hospital Lankenau Wynnewood, PA
- Paoli Hospital Paoli, PA
- Bryn Mawr Hospital Bryn Mawr, PA
- Riddle Memorial Hospital Media, PA
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 691
- Services billed
- 1,110
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 405 | 310 |
| Established patient office or other outpatient visit, 30-39 minutes | 349 | 251 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 162 | 154 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 100 | 70 |
| Established patient office or other outpatient visit, 40-54 minutes | 52 | 39 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 49 | 48 |
| New patient office or other outpatient visit, 30-44 minutes | 18 | 18 |
| New patient office or other outpatient visit, 60-74 minutes | 16 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metformin Hcl Other prescribers in Wynnewood, PA | 501 |
| Synthroid (levothyroxine sodium) Other prescribers in Wynnewood, PA | 429 |
| Ozempic (semaglutide) Other prescribers in Wynnewood, PA | 308 |
| Levothyroxine Sodium Other prescribers in Wynnewood, PA | 285 |
| Novolog Flexpen (insulin aspart) Other prescribers in Wynnewood, PA | 254 |
| Lantus Solostar (insulin glargine,hum.rec.anlog) Other prescribers in Wynnewood, PA | 201 |
| Nano 2nd Gen Pen Needle (pen needle, diabetic) Other prescribers in Wynnewood, PA | 200 |
| Mounjaro (tirzepatide) Other prescribers in Wynnewood, PA | 168 |
| Jardiance (empagliflozin) Other prescribers in Wynnewood, PA | 162 |
| Rosuvastatin Calcium Other prescribers in Wynnewood, PA | 150 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 18 payments worth $20,364 in total to this clinician.
| Novo Nordisk Inc | $17,190 |
|---|---|
| AbbVie Inc. | $3,150 |
| Abbott Laboratories | $24.03 |
| Compensation for services other than consulting (speaking, faculty) | $18,681 |
|---|---|
| Travel and Lodging | $1,204 |
| Food and Beverage | $479 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novo Nordisk Inc Mar 8, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $5,737 |
| Novo Nordisk Inc Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $2,093 |
| Novo Nordisk Inc Oct 29, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $2,093 |
| Novo Nordisk Inc Mar 19, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $2,093 |
| Novo Nordisk Inc Nov 9, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $2,093 |
| AbbVie Inc. May 20, 2025 | Compensation for services other than consulting (speaking, faculty) SYNTHROID · IMMUNOLOGY | $1,575 |
| AbbVie Inc. Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) SYNTHROID · IMMUNOLOGY | $1,575 |
| Novo Nordisk Inc Feb 24, 2025 | Compensation for services other than consulting (speaking, faculty) Rybelsus · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $930 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $538 |
| Novo Nordisk Inc Oct 7, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $494 |
All 14 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Novo Nordisk Inc Nov 9, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $2,093 |
| Novo Nordisk Inc Nov 9, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Ardmore, PA · in-kind | $34.30 |
| Novo Nordisk Inc Oct 29, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $2,093 |
| AbbVie Inc. Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) SYNTHROID · IMMUNOLOGY | $1,575 |
| Novo Nordisk Inc Oct 7, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $494 |
| AbbVie Inc. May 20, 2025 | Compensation for services other than consulting (speaking, faculty) SYNTHROID · IMMUNOLOGY | $1,575 |
| Novo Nordisk Inc Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $2,093 |
| Novo Nordisk Inc Mar 19, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $2,093 |
| Novo Nordisk Inc Mar 8, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $5,737 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $538 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $399 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $222 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $10.00 |
| Novo Nordisk Inc Feb 24, 2025 | Compensation for services other than consulting (speaking, faculty) Rybelsus · Diabetes Company’s descriptionThe reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient. | $930 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.